tiprankstipranks
Trending News
More News >
Evaxion Biotech A/S Adr (EVAX)
:EVAX
US Market

Evaxion Biotech (EVAX) Income Statement

Compare
384 Followers

Evaxion Biotech Income Statement

Last quarter (Q3 2025), Evaxion Biotech's total revenue was $7.49M, an increase of 6040.98% from the same quarter last year. In Q3, Evaxion Biotech's net income was $4.62M. See Evaxion Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 3.34M$ 73.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ 3.34M$ 73.00K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 18.08M$ 22.27M$ 25.26M$ 25.83M$ 16.57M
Depreciation and Amortization
$ 607.00K$ 615.00K$ 571.00K$ 344.00K$ 105.00K
EBITDA
$ -9.79M$ -21.40M$ -22.57M$ -24.21M$ -16.46M
Operating Income
$ -14.73M$ -22.20M$ -25.26M$ -25.83M$ -16.57M
Other Income/Expenses
$ 3.38M$ -718.00K$ 1.32M$ 1.12M$ -7.00K
Pretax Income
$ -11.36M$ -22.91M$ -23.94M$ -24.71M$ -16.57M
Net Income
$ -10.57M$ -22.13M$ -23.17M$ -24.53M$ -15.02M
Per Share Metrics
Basic EPS
$ -9.80$ -32.40$ -39.20$ -50.40$ -37.00
Diluted EPS
$ -9.80$ -32.40$ -39.20$ -50.40$ -37.00
Weighted Average Shares Outstanding
1.07M 683.39K 590.97K 487.33K 404.97K
Weighted Average Shares Outstanding (Diluted)
1.07M 683.39K 590.97K 487.33K 404.97K
Currency in USD

Evaxion Biotech Earnings and Revenue History